AI Revolutionizes Cancer Drug Discovery with Faster, Personalized Therapies
AI is transforming the landscape of cancer drug discovery by enabling faster and more personalized treatment development. Recent advancements have allowed AI to accelerate the identification of promising drug candidates and improve patient stratification. However, challenges such as data bias, regulatory uncertainty, and insufficient clinical validation remain. AI-driven drug discovery has led to the development of AI-generated small molecules that have entered clinical trials, showcasing the potential for AI to revolutionize precision oncology. Despite these advancements, the integration of AI in drug development faces hurdles that need to be addressed to maximize its potential. 
